Roupen Odabashian: AI in clinical decision support… Without clinicians?
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post on LinkedIn:
“AI in Clinical Decision Support… Without Clinicians?
I recently attended a talk about AI in clinical decision support. Five speakers on the panel. Zero physicians.
How are we discussing tools meant to support clinical decisions – without including the people who actually make those decisions?
It’s not just panels. It’s the system.
Private equity firms are buying up cardiology practices.
Non-physicians – many with MBAs – are acquiring the very places where physicians do their work. (Nothing wrong with people with an MBA, but the practice of medicine is not only about profit margin)
And then, they’re the ones telling us what tools to use, how many patients to see, and where to work.
Physicians are being reduced to highly paid contractors.
With all due respect, this is not sustainable.
We need to wake up. If we stay quiet, in 10 years we may not even recognize our own profession.
This isn’t just frustrating – it’s unbelievable. The presumed high salary that is given is worse than drugs!”
More posts featuring Roupen Odabashian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023